Persistent symptoms and spirometric values after mild and moderate COVID-19
Retrospective study
Abstract
Objective: To describe persistent symptoms and spirometric values in mild and moderate post-COVID-19 patients.
Materials and methods: Observational and retrospective study that recruited 90 patients with mild to moderate COVID-19 for post-infection follow-up. At reassessment, spirometry testing was performed and clinical data were collected, including assessment of symptoms and dyspnea using the modified Medical Research Council (mMRC) scale.
Results: Persistence of at least one post-COVID-19 symptom was identified in 84 (93%) subjects, with headache followed by cough and muscle fatigue being the most prevalent. The spirometric evaluation identified 38 (42.2%) with a restrictive pattern, 37 (41.1%) patients with a normal pattern, and 15 (16.7%) with an obstructive pattern,. The median perception of dyspnea according to the mMRC was 2 (IQR 1-3) points. Significant differences were only observed in the mMRC when comparing the normal versus the restrictive pattern (p=0.002).
Conclusion: This study investigated symptom persistence and spirometric patterns in patients with mild and moderate COVID-19, revealing a predominant prevalence of restrictive and normal patterns in spirometry tests. Although no significant differences in symptoms were observed between the groups as defined by spirometry, the high prevalence of persistent symptoms (93%), such as headache, cough and muscle fatigue, is noteworthy.
References
Cortés-Telles A, López-Romero S, Figueroa-Hurtado E, Pou-Aguilar YN, Wong AW, Milne KM, Ryerson CJ, Guenette JA. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021 Jun;288:103644. doi: 10.1016/j.resp.2021.103644. doi: 10.1016/j.resp.2021.103644
Crossref
| Google Scholar
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601-615. doi: 10.1038/s41591-021-01283-z. doi: 10.1038/s41591-021-01283-z
Crossref
| Google Scholar
Contreras PJ, Romero-Albino Z, Cuba-Fuentes MS. Descripción de síntomas frecuentes y persistentes de COVID-19 en asistentes a centros del adulto mayor. Medwave. Enero 2022. [Citado 21 de abril de 2022];Disponible en: https://www.medwave.cl/investigacion/estudios/8689.html doi: 10.5867/medwave.2022.01.002510 doi: 10.5867/medwave.2022.01.002510
Crossref
| Google Scholar
Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026. doi: 10.1136/bmj.m3026
Crossref
| Google Scholar
Gao Y, Liang WQ, Li YR, He JX, Guan WJ. The Short- and Long-Term Clinical, Radiological and Functional Consequences of COVID-19. Arch Bronconeumol. 2022 Apr;58:32-38. doi: 10.1016/j.arbres.2022.03.006. doi: 10.1016/j.arbres.2022.03.006
Crossref
| Google Scholar
Laveneziana P, Sesé L, Gille T. Pathophysiology of pulmonary function anomalies in COVID-19 survivors. Breathe (Sheff). 2021 Sep;17(3):210065. doi: 10.1183/20734735.0065-2021. doi: 10.1183/20734735.0065-2021
Crossref
| Google Scholar
Gerardo AM, Almeida T, Maduro S, Carvalho M, Boléo-Tomé JP, Liberato H. Pulmonary Function, Functional Capacity and Health Status in COVID-19 Survivors. Rev Med Clin. 2021;5(2),e11052105023. doi:10.5281/zenodo.4749635
Lopes AJ. Advances in spirometry testing for lung function analysis. Expert Rev Respir Med. 2019 Jun;13(6):559-569. doi: 10.1080/17476348.2019.1607301 doi: 10.1080/17476348.2019.1607301
Crossref
| Google Scholar
Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, et al; COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021 Mar;82(3):378-383. doi: 10.1016/j.jinf.2021.01.004. doi: 10.1016/j.jinf.2021.01.004
Crossref
| Google Scholar
Osikomaiya B, Erinoso O, Wright KO, Odusola AO, Thomas B, Adeyemi O, et al. 'Long COVID': persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect Dis. 2021 Mar 25;21(1):304. doi: 10.1186/s12879-020-05716-x. doi: 10.1186/s12879-020-05716-x
Crossref
| Google Scholar
Cabrera Martimbianco AL, Pacheco RL, Bagattini ÂM, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. 2021 Oct;75(10):e14357. doi: 10.1111/ijcp.14357. doi: 10.1111/ijcp.14357
Crossref
| Google Scholar
Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, Vilaró J. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. 2021 Jul-Aug;27(4):328-337. doi: 10.1016/j.pulmoe.2020.10.013. doi: 10.1016/j.pulmoe.2020.10.013
Crossref
| Google Scholar
Organización Mundial de la Salud. Clinical management of COVID-19. [Internet]. 2022 [citado 27 de septiembre de 2022]. Disponible en: https://www.who.int/teams/health-care-readiness/covid-19
Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST. doi: 10.1164/rccm.201908-1590ST
Crossref
| Google Scholar
Rivero-Yeverino D. Espirometría: conceptos básicos [Spirometry: basic concepts]. Rev Alerg Mex. 2019 Jan-Mar;66(1):76-84. Español. doi: 10.29262/ram.v66i1.536. doi: 10.29262/ram.v66i1.536
Crossref
| Google Scholar
Williams N. The MRC breathlessness scale. Occup Med (Lond). 2017 Aug 1;67(6):496-497. doi: 10.1093/occmed/kqx086. doi: 10.1093/occmed/kqx086
Crossref
| Google Scholar
Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al; TLC Study Group. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021 Sep;114(9):428-442. doi: 10.1177/01410768211032850. doi: 10.1177/01410768211032850
Crossref
| Google Scholar
van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022 Jan 19;39(1):159-167. doi: 10.1093/fampra/cmab076. doi: 10.1093/fampra/cmab076
Crossref
| Google Scholar
Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021 Sep;6(9):e005427. doi: 10.1136/bmjgh-2021-005427. doi: 10.1136/bmjgh-2021-005427
Crossref
| Google Scholar
Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022 Feb;23(2):194-202. doi: 10.1038/s41590-021-01104-y. doi: 10.1038/s41590-021-01104-y
Crossref
| Google Scholar
Song WJ, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, Chung KF. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021 May;9(5):533-544. doi: 10.1016/S2213-2600(21)00125-9. doi: 10.1016/S2213-2600(21)00125-9
Crossref
| Google Scholar
Carod-Artal FJ. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol. 2021 Jun 1;72(11):384-396. English, Spanish. doi: 10.33588/rn.7211.2021230. doi: 10.33588/rn.7211.2021230
Crossref
| Google Scholar
Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data. Front Med (Lausanne). 2021 May 4;8:653516. doi: 10.3389/fmed.2021.653516. doi: 10.3389/fmed.2021.653516
Crossref
| Google Scholar
Townsend L, Dowds J, O'Brien K, Sheill G, Dyer AH, O'Kelly B, et al. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc. 2021 Jun;18(6):997-1003. doi: 10.1513/AnnalsATS.202009-1175OC. doi: 10.1513/AnnalsATS.202009-1175OC
Crossref
| Google Scholar










